Table 1:
Patient and specimen characteristics
| Specimens | Patients | ||
|---|---|---|---|
| Number Specimens | 1259 | Number Patients | 135 |
| Voided (%) | 1110 (88.2) | Age (mean (SD)) | 71.50 (12.26) |
| Prior History Hematuria (%) | 172 (13.7) | Sex = M (%) | 102 (75.6) |
| Diagnosis (%) | First Positive Primary Tumor Stage/Grade (%) | ||
| Negative | 815 (64.7) | 0is | 7 (5.2) |
| Atypical | 298 (23.7) | T1 | 35 (25.9) |
| Suspicious | 98 (7.8) | TaLG (non-invasive low grade) | 33 (24.4) |
| Positive | 48 (3.8) | TaHG (non-invasive high grade) | 60 (44.4) |
| Contains Artifact (%) | 265 (21.0) | Carcinoma in situ (%) | 18 (13.3) |
| Treatment (%) | |||
| BCG | 71 (52.6) | ||
| Mitomycin | 9 (6.7) | ||
| No Treatment | 37 (27.4) | ||
| Unavailable | 18 (13.3) | ||
| Number of Recurrences (%) | |||
| 0 | 42 (31.1) | ||
| 1 | 73 (54.1) | ||
| 2 | 13 (9.6) | ||
| 3+ | 7 (5.2) | ||